Molnupiravir is an orally active antiviral prodrug classified as a cytidine analog that functions by inducing RNA polymerase errors to inhibit the replication of RNA viruses such as COVID-19. This category… Read more







![Chemical structure of ((3aR,4R,6R,6aR)-6-(2,4-bis(Hydroxyamino)pyrimidin-1(2H)-yl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methyl Isobutyrate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F3aR4R6R6aR-6-24-bisHydroxyaminopyrimidin-12H-yl-22-dimethyltetrahydrofuro34-d13dioxol-4-ylmethyl-Isobutyrate.png&w=3840&q=75)
![Chemical structure of ((3aR,4R,6R,6aR)-6-(2,4-dioxo-3,4-Dihydropyrimidin-1(2H)-yl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methyl isobutyrate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2346620-53-7-3aR4R6R6aR-6-24-dioxo-34-Dihydropyrimidin-12H-yl-22-dimethyltetrahydrofuro34-d13dioxol-4-ylmethyl-isobutyrate.png&w=3840&q=75)
![Chemical structure of ((3aR,4R,6R,6aR)-6-(4,6-Bis(hydroxyamino)-2-oxo-5,6-dihydropyrimidin-1(2H)-yl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methyl Isobutyrate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F3aR4R6R6aR-6-46-Bishydroxyamino-2-oxo-56-dihydropyrimidin-12H-yl-22-dimethyltetrahydrofuro34-d13dioxol-4-ylmethyl-Isobutyrate.png&w=3840&q=75)
![Chemical structure of ((3aR,4R,6R,6aR)-6-(4-(Hydroxyimino)-2-oxo-3,4-dihydropyrimidin-1(2H)-yl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methyl isobutyrate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2346620-55-9-3aR4R6R6aR-6-4-Hydroxyimino-2-oxo-34-dihydropyrimidin-12H-yl-22-dimethyltetrahydrofuro34-d13dioxol-4-ylmethyl-isobutyrate.png&w=3840&q=75)
![Chemical structure of ((3aR,4R,6R,6aR)-6-(4-Amino-2-oxopyrimidin-1(2H)-yl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methyl isobutyrate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1686124-74-2-3aR4R6R6aR-6-4-Amino-2-oxopyrimidin-12H-yl-22-dimethyltetrahydrofuro34-d13dioxol-4-ylmethyl-isobutyrate.png&w=3840&q=75)




![Chemical structure of [13C,15N2]-N4-Hydroxycytidine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F13C15N2-N4-Hydroxycytidine.png&w=3840&q=75)







Molnupiravir is an orally active antiviral prodrug classified as a cytidine analog that functions by inducing RNA polymerase errors to inhibit the replication of RNA viruses such as COVID-19. This category provides a comprehensive range of Molnupiravir reference standards, including the active pharmaceutical ingredient, synthetic intermediates, and various related compounds. Pharmaceutical laboratories utilize these materials for rigorous impurity profiling, ensuring that process-related impurities, synthetic byproducts, and potential degradation products are identified and quantified during quality control. Stable isotope labelled Molnupiravir compounds are essential tools for mass spectrometry-based analytical testing, allowing for precise quantification and method validation across complex matrices. By incorporating these pharmacopeial and non-pharmacopeial standards, researchers and quality control departments can maintain regulatory compliance and verify the quality and safety of the drug substance throughout the manufacturing and formulation processes.